Contract research projects aiming at the design and synthesis of new molecules for different diseases, such as cancer, neurodegenerative and infectious diseases, among others, using two different approaches: computer-aided drug discovery and semisynthetic derivatization. Biological validation of the most promising molecules will be performed, depending on the type of disease.

Furthermore, custom synthesis of small organic molecules, process optimization, virtual screening, and ADMET prediction are also know-hows that can be provided.